Esophagogastric junction morphology and contractile integral on high-resolution manometry in asymptomatic healthy volunteers: An international multicenter study.


Journal

Neurogastroenterology and motility
ISSN: 1365-2982
Titre abrégé: Neurogastroenterol Motil
Pays: England
ID NLM: 9432572

Informations de publication

Date de publication:
06 2021
Historique:
revised: 22 08 2020
received: 19 06 2020
accepted: 21 09 2020
pubmed: 24 10 2020
medline: 11 1 2022
entrez: 23 10 2020
Statut: ppublish

Résumé

Esophagogastric junction contractile integral (EGJ-CI) and EGJ morphology are high-resolution manometry (HRM) metrics that assess EGJ barrier function. Normative data standardized across world regions and HRM manufacturers are limited. Our aim was to determine normative EGJ metrics in a large international cohort of healthy volunteers undergoing HRM (Medtronic, Laborie, and Diversatek software) acquired from 16 countries in four world regions. EGJ-CI was calculated by the same two investigators using a distal contractile integral-like measurement across the EGJ for three respiratory cycles and corrected for respiration (mm Hg cm), using manufacturer-specific software tools. EGJ morphology was designated according to Chicago Classification v3.0. Median EGJ-CI values were calculated across age, genders, HRM systems, and regions. Of 484 studies (28.0 years, 56.2% F, 60.7% Medtronic studies, 26.0% Laborie, and 13.2% Diversatek), EGJ morphology was type 1 in 97.1%. Median EGJ-CI was similar between Medtronic (37.0 mm Hg cm, IQR 23.6-53.7 mm Hg cm) and Diversatek (34.9 mm Hg cm, IQR 22.1-56.1 mm Hg cm, P = 0.87), but was significantly higher using Laborie equipment (56.5 mm Hg cm, IQR 35.0-75.3 mm Hg cm, P < 0.001). 5 EGJ morphology is predominantly type 1 in healthy adults. EGJ-CI varies widely in health, with significant gender influence, but is consistent within each HRM system. Manufacturer-specific normative values should be utilized for clinical HRM interpretation.

Sections du résumé

BACKGROUND
Esophagogastric junction contractile integral (EGJ-CI) and EGJ morphology are high-resolution manometry (HRM) metrics that assess EGJ barrier function. Normative data standardized across world regions and HRM manufacturers are limited.
METHODS
Our aim was to determine normative EGJ metrics in a large international cohort of healthy volunteers undergoing HRM (Medtronic, Laborie, and Diversatek software) acquired from 16 countries in four world regions. EGJ-CI was calculated by the same two investigators using a distal contractile integral-like measurement across the EGJ for three respiratory cycles and corrected for respiration (mm Hg cm), using manufacturer-specific software tools. EGJ morphology was designated according to Chicago Classification v3.0. Median EGJ-CI values were calculated across age, genders, HRM systems, and regions.
RESULTS
Of 484 studies (28.0 years, 56.2% F, 60.7% Medtronic studies, 26.0% Laborie, and 13.2% Diversatek), EGJ morphology was type 1 in 97.1%. Median EGJ-CI was similar between Medtronic (37.0 mm Hg cm, IQR 23.6-53.7 mm Hg cm) and Diversatek (34.9 mm Hg cm, IQR 22.1-56.1 mm Hg cm, P = 0.87), but was significantly higher using Laborie equipment (56.5 mm Hg cm, IQR 35.0-75.3 mm Hg cm, P < 0.001). 5
CONCLUSIONS
EGJ morphology is predominantly type 1 in healthy adults. EGJ-CI varies widely in health, with significant gender influence, but is consistent within each HRM system. Manufacturer-specific normative values should be utilized for clinical HRM interpretation.

Identifiants

pubmed: 33094875
doi: 10.1111/nmo.14009
pmc: PMC9380029
mid: NIHMS1829170
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14009

Subventions

Organisme : NIDDK NIH HHS
ID : P01 DK117824
Pays : United States

Informations de copyright

© 2020 John Wiley & Sons Ltd.

Références

Neurogastroenterol Motil. 2015 Feb;27(2):160-74
pubmed: 25469569
Neurogastroenterol Motil. 2015 Oct;27(10):1423-31
pubmed: 26227513
Arq Gastroenterol. 2020 Apr-Jun;57(2):209-215
pubmed: 32401949
Dis Esophagus. 2015 Oct;28(7):684-90
pubmed: 25082444
World J Gastroenterol. 2017 Apr 21;23(15):2785-2794
pubmed: 28487616
Dis Esophagus. 2016 Oct;29(7):820-828
pubmed: 26173375
J Gastroenterol Hepatol. 2017 Aug;32(8):1443-1449
pubmed: 28061013
Neurogastroenterol Motil. 2017 Dec;29(12):
pubmed: 28544357
Neurogastroenterol Motil. 2016 May;28(5):639-46
pubmed: 26768087
Gastroenterology. 2005 Jan;128(1):209-24
pubmed: 15633138
J Am Coll Surg. 2011 Dec;213(6):743-50
pubmed: 22107919
N Engl J Med. 1997 Mar 27;336(13):924-32
pubmed: 9070474
Neurogastroenterol Motil. 2014 Mar;26(3):353-60
pubmed: 24460814
Neurogastroenterol Motil. 2003 Dec;15(6):591-606
pubmed: 14651595
Neurogastroenterol Motil. 2020 Mar;32(3):e13750
pubmed: 31633258
J Neurogastroenterol Motil. 2017 Jan 30;23(1):27-33
pubmed: 27426485
Neurogastroenterol Motil. 2011 Nov;23(11):e461-9
pubmed: 21595803
Gastrointest Endosc Clin N Am. 2014 Oct;24(4):527-43
pubmed: 25216901
Neurogastroenterol Motil. 2015 Aug;27(8):1175-82
pubmed: 26010058
Gut. 2018 Jul;67(7):1351-1362
pubmed: 29437910
Neurogastroenterol Motil. 2018 Sep;30(9):e13344
pubmed: 29644765
Am J Gastroenterol. 2007 May;102(5):1056-63
pubmed: 17319930

Auteurs

Benjamin D Rogers (BD)

Division of Gastroenterology, Washington University School of Medicine, St Louis, MO, USA.

Arvind Rengarajan (A)

Division of Gastroenterology, Washington University School of Medicine, St Louis, MO, USA.

Luiz Abrahao (L)

University Hospital Clementino Fraga Filho, Rio de Janeiro, Brazil.

Shobna Bhatia (S)

Department of Gastroenterology, Sir HN Reliance Foundation Hospital, Mumbai, India.

Serhat Bor (S)

Department of Gastroenterology, Ege University, Izmir, Turkey.

Dustin A Carlson (DA)

Division of Gastroenterology and Hepatology, Northwestern University, Chicago, IL, USA.

Daniel Cisternas (D)

Clínica Alemana de Santiago, Facultad de Medicina, Universidad del Desarrollo, Santiago de Chile, Chile.

Sutep Gonlachanvit (S)

Center of Excellence on Neurogastroenterology and Motility, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Albis Hani (A)

Departamento de Gastroenterología y Laboratorio de Motilidad, Hospital Universitario San Ignacio, Pontificia Universidad Javeriana, Bogotá, Colombia.

Jamal Hayat (J)

Department of Gastroenterology, St. George's University Hospitals NHS Trust, London, UK.

Osamu Kawamura (O)

Department of Gastroenterology, Kamimoku SPA Hospital, Minakami, Gunma, Japan.

Yeung Yeh Lee (YY)

School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu, Malaysia.
Gut Research Group, Faculty of Medicine, National University of Malaysia, Kuala Lumpur, Malaysia.

Ana Maria Leguizamo (AM)

Departamento de Gastroenterología y Laboratorio de Motilidad, Hospital Universitario San Ignacio, Pontificia Universidad Javeriana, Bogotá, Colombia.

Ans Pauwels (A)

Department of Gastroenterology, Catholic University of Leuven, Leuven, Belgium.

Julio Perez de la Serna (J)

Unidad de Motilidad, Servicio de Aparto Digestivo, Hospital Clinico San Carlos, Madrid, Spain.

Rosa I Ramos (RI)

Motility Lab, Department of Gastroenterology, British Hospital and El Cruce Hospital, Buenos Aires, Argentina.

Jose Maria Remes-Troche (JM)

Digestive Physiology and Motility Lab, Medical Biological Research Institute, Universidad Veracruzana, Veracruz, México.

Sabine Roman (S)

Digestive Physiology, Hospices Civils de Lyon, Hopital E Herriot, Université de Lyon, Lyon, France.
Digestive Physiology, Université de Lyon, Lyon I University, Lyon, France.

Edoardo Savarino (E)

Division of Gastroenterology, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.

Jordi Serra (J)

Motility and Functional Gut Disorders Unit, University Hospital Germans Trias I Pujol. CIBERehd, Badalona, Barcelona, Spain.

Daniel Sifrim (D)

Upper GI Physiology Unit, Barts and the London School of Medicine and Dentistry, London, UK.

Salvatore Tolone (S)

General, Mininvasive and Bariatric Surgery Unit, University of Campania Luigi Vanvitelli, Naples, Italy.

Zhiqin Wong (Z)

Gut Research Group, Faculty of Medicine, National University of Malaysia, Kuala Lumpur, Malaysia.

Frank Zerbib (F)

CHU de Bordeaux, Centre Medico-Chirurgical Magellan, Hôpital Haut-Lévêque, Gastroenterology Department, Université de Bordeaux, Bordeaux, France.

John Pandolfino (J)

Division of Gastroenterology and Hepatology, Northwestern University, Chicago, IL, USA.

C Prakash Gyawali (CP)

Division of Gastroenterology, Washington University School of Medicine, St Louis, MO, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH